FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 23, 2016--
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that Kelly A. Kramer
has been appointed to the company’s Board of Directors and Audit
Committee.
Ms. Kramer is currently Executive Vice President and Chief Financial
Officer of Cisco Systems, Inc., which designs and sells products,
services and solutions to securely connect everyone and everything. She
previously served for 20 years in senior finance positions at General
Electric, including as Chief Financial Officer of GE Healthcare’s
Healthcare Systems Business. She is a member of the board of the Silicon
Valley Chapter of City Year, a non-profit organization that provides
educational support for at-risk students in poor communities.
“We are very pleased to welcome Kelly Kramer to the Board of Directors
of Gilead Sciences,” said John Martin, PhD, Executive Chairman of
Gilead’s Board of Directors. “Kelly’s deep financial expertise in the
technology and healthcare industries, including mergers and
acquisitions, will be valuable as Gilead continues to grow across
multiple therapeutic areas and around the world. I look forward to the
contributions and insights that she will bring to the Board.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Gilead has operations in more
than 30 countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160823005469/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.InvestorsSung Lee, 650-524-7792orMediaMichele
Rest, 650-577-6935
